Silence Therapeutics Share Discussion Threads

[rogen83] 04/10/2017 16:35

There isn’t much to derail this near term. On the contrary you can sense the sentiment building quite nicely - Alnylam phase 3 was a game changer

[1gw] 04/10/2017 15:25

I guess the question is whether they can keep the excitement going until the capital markets event on 14th November, and indeed whether if 200p holds the excitement might build towards that event as momentum players come in (I keep hoping for some of this).

While I feel a certain temptation to take some profit above 200p, I'm not sure there's any obvious near-term catalyst for a meaningful pullback until 14th November, when there might be some "sell on the news" if the price has run up ahead of the event.

[rogen83] 04/10/2017 15:16

200p breached

[1gw] 04/10/2017 13:35

Great to see some 200p trades going through.

[gersemi] 04/10/2017 07:04

MTFB news just in - she's gonna explode on today's news

[rogen83] 04/10/2017 06:54

Arrowhead at 10 month highs

[gersemi] 04/10/2017 04:48

Sold 50% and stuck it into MTFB (Beaufort Securities price target of 100p) though I do reckon there's still 300p in Silence, in time

[ukeagle2aus] 04/10/2017 04:41

This will make some long term posters smile (if they are still around).

It must be at least 13 or 14 years since my first SR Pharma investment and I have a significant loss over that time. But I am at last ready to rekindle my interest and look to get something back as my poor sixth sense, finally says the end game is not to far away.

It's a relatively lower investment than the heady days, but I have instructed my broker to cash in everything else and go all in on SLN. So Bare, Doc,Frog, Buzzzz,Graham Browns Dad,Billy,Tonester,Digger,Geoffmanana,Sawbones,JBD, Rick and lots of others from the past (apologies for my poor memory)let's hope this is ends up being one for the old crowd! GLA

[rogen83] 29/9/2017 06:52

How long till we get an approach? Tick tock

[1gw] 28/9/2017 21:15

Another very nice day for ARWR shareholders (up another 7% to $4.22). I bottled it on analyst day, so no longer have a direct interest, but might it be enough to push SLN through 200p tomorrow?

[1gw] 28/9/2017 16:40

So close...

[djnzloop] 28/9/2017 15:45

1gw today is the day!

[1gw] 28/9/2017 11:04

Could this be the day the share price gets back through 200p?

[rogen83] 28/9/2017 08:23

Arrowhead stake now worth £20m or 30p of SLNs share price

Good work Ali

[1gw] 27/9/2017 10:22

Looking at the various holdings notices, I wonder if RG, RK, Spreadex and ING positions are linked.

RG & RK notified 4.63% spreadbet position as of 20th September.
Spreadex has notified 5.49% spreadbet position also as of 20th September.
ING notified 5.35% shares position as of 20th September.

So is it likely that the spreadex position is mainly the other side of the RG & RK positions, while the ING position is mainly the underlying asset to cover spreadex? If that's correct then (most of) the ING and spreadex positions have to be ignored when calculating the number of voting rights controlled by top shareholders, otherwise there's double-counting.

Given the 0.72% increase in the ING position as of 25th September, perhaps RG and/or RK have increased their spreadbet positions a bit as of that date.

[doc robinson] 26/9/2017 07:46

Arrowhead up 20% all good for sln investment

[1gw] 22/9/2017 20:52

Good call on Woodford, djnzloop. So with Woodford below the notifiable threshold, I think the major shareholders, with total positions including derivatives, are now:

29.2% Richard Griffiths
20.6% Robert Keith
11.9% Invesco (from Annual Report)
7.7% Henderson (from Annual Report)
5.3% ING
5.3% Aviva

That's 80% held between the top 6 investors, with another 2.8% held by Ali (according to annual report).

Is it credible that ING is holding that position for its own account, or is it likely to be on behalf of a client or as the underlying asset for a derivative offered to a client?

[rogen83] 22/9/2017 18:59

The more held in just a few hands the better. Liquidity is going to be at a premium so any whiff of a deal and this is going to squeeze like buggary

[richie666] 22/9/2017 16:02

Griffiths & Keith now own near 50% - the picture is complete and once more, an absolute work of art to watch.

[1gw] 22/9/2017 15:27

Robert Keith up as well.

[callumross] 22/9/2017 14:21

So Aviva sold down on Wednesday but ING and more interestingly Richard Griffiths increased their holdings. Reassuring to see RG increasing as he has held for long time, and especially reassuring that the increase is all to "Richard Griffiths & Family" rather than one of his subsidiary companies. If he still sees value adding at these levels, that is good enough for me.

[1gw] 22/9/2017 09:42

callumross - I don't think the £8.56m is materially inaccurate, just a bit confusing. They are quoting the book value at 30th June, where "available for sale financial assets" were in the accounts at £8.555m.

However, I do think the "up over 200%" is inaccurate. Silence purchased the stake at an average price of $1.65, so at a current price of about $3.50, the increase is $1.85, which is an increase of 112%, so the stake in $ terms is up over 100% since purchase, not over 200%.

"That capitalises the business still at just £133 million with the valuation being backed by net cash of £29.8 million as at 30th June along with shares in US listed peer Arrowhead Pharmaceuticals (ARWR) valued at £8.56 million and which are up over 200% since Silence’s purchase."

[callumross] 22/9/2017 09:26

There is a material inaccuracy in that Align Research report Richie. They state the value of the Arrowhead stake as £8.56m. In fact at last nights close of $3.50 it is worth $24m or around £18m.

[1gw] 22/9/2017 07:54

Interesting that Align Research have put a link to their Silence update out this morning in an official RNS, entitled "Align Research updates"

[doc robinson] 22/9/2017 07:19

Note sounds very positive and is confident silence will be bought out very soon at a substantial premium.